Bedsore. Stage III decubitus ulcer
Conditions
Interventions
Intervention 1: Formulation of 10% of this herb will be used as a vanishing cream in experimental group for a month. Intervention 2: No intervention will be done in control group and usual cream will
Treatment - Drugs
Formulation of 10% of this herb will be used as a vanishing cream in experimental group for a month.
No intervention will be done in control group and usual cream will be used
Sponsors
Vice chancellor for research, Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
All
Age
3 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: More than 3 days has not passed from wounding; The size of the wound has not caught more than 10% of body surface. Exclusion criteria: Patients with secondary infection; Pregnant or lactating women; Patients treated with immunosuppressant drugs and patients with infected wounds that require treatment with antibiotics; Patients who take drugs with wound healing properties such as corticosteroid.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Wound area. Timepoint: Baseline, days of 7, 14 and 28. Method of measurement: Visit by dermatologist. | — |
Countries
Iran (Islamic Republic of)
Outcome results
None listed